Results 171 to 180 of about 114,207 (263)

Blood Labyrinth Barrier Waste Clearance as Assessed by GBCAs on MRI: A Scoping Review. [PDF]

Laryngoscope Investig Otolaryngol
Ahmad SA, Huang EY, Kim JS, Balhi Y, Spann M, Ward BK.   +5 more
europepmc   +1 more source

Gadoxetic Acid-enhanced MRI Radiomics Features of Tumor Margins for Predicting High-Risk Solitary Hepatocellular Carcinoma Aggressiveness and Prognosis. [PDF]

Radiol Imaging Cancer
Yu C, Wang X, Tang S, Li Y, Han S, Zhang Q, Qu J, Xu H, Zhou Y.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gadolinium-DTPA in spinal disease.

Radiologic Clinics of North America, 1988
The use of paramagnetic contrast agents, in particular, gadolinium-DTPA, holds great promise for the MR evaluation of the spine. However, because of the lack of a previous model for intravenous contrast enhancement in the spine and because of some ...
G. Sze
semanticscholar   +3 more sources

MR imaging of the breast using gadolinium-DTPA.

Journal of Computer Assisted Tomography, 1986
In a preliminary study 20 patients underwent breast examinations by magnetic resonance (MR) imaging without and with Gd-DTPA as contrast medium. All carcinomas enhanced, whereas dysplastic tissue enhanced slightly or not at all. Significant additional diagnostic information was available on the Gd-DTPA examinations in at least four of 20 cases compared
S. Heywang, D. Hahn, H. Schmidt, I. Krischke, W. Eiermann, R. Bassermann, J. Lissner   +6 more
semanticscholar   +3 more sources

Elimination of gadolinium–DTPA by peritoneal dialysis

Nephrology Dialysis Transplantation, 1995
Magnetic resonance urography (MRU) after i.v. injection of gadolinium-DTPA (0.1 mmol/kg bodyweight) was performed in a patient with transplant dysfunction after renal allograft transplantation. Renal replacement therapy was accomplished by means of peritoneal dialysis.
J. Dörsam, M. V. Knopp, L. Schad, S. Piesche, S. Carl, N. Oesingmann   +5 more
exaly   +4 more sources

Gadolinium-DTPA-enhanced MRI of intraocular tumors

Magnetic Resonance Imaging, 1990
The value of gadolinium-enhanced MRI in 30 patients with intraocular lesions has been evaluated. Seventeen patients had a uveal melanoma, two a ciliary body melanoma, three had uveal metastases, one lymphoma, four had senile macula degenerations, and three uveal nevi.
Rolf Wilhelm Günther
exaly   +3 more sources

Safety of gadolinium‐DTPA: Extended clinical experience

Magnetic Resonance in Medicine, 1991
AbstractThis review reports data on the general and renal tolerance of the paramagnetic contrast agent Gd‐DTPA after intravenous administration. Gd‐DTPA was administered usually at a dose level of 0.1‐0.2 mmol/kg body wt (range: 0.005‐0.25 mmol/kg body wt) in cranial, spinal and body MR indications.
Niendorf Hp, J. Haustein, I. Cornelius, A. Alhassan, W. Clauss   +4 more
semanticscholar   +3 more sources

Radiation myelopathy: significance of gadolinium-DTPA enhancement in the diagnosis

Neuroradiology, 1991
We described two cases of chronic progressive radiation myelopathy (CPRM), in which magnetic resonance imaging (MRI) was of great value for the diagnosis. Gadolinium-DTPA (Gd-DTPA) enhancement delineated precise lesions responsible for Brown-Séquard syndrome caused by CPRM in both cases.
Toshiki Uchihara
exaly   +3 more sources